Algernon Pharmaceuticals Inc (AGNPF)

[lazyeye]

Not fishy at all. Simple supply vs demand equation. The sizzle has been sold and the steak hasn't. .07 to .36 the past month or so ain't too shabby, but was all Covid related. Those buyers are gone now and with the world getting back to normal somewhat, and new treatments getting hyped, the allure of this stock unfortunately has waned. That doesn't mean this can't giddyap over the coming weeks, but it needs to give potential buyers some new positive news, data, etc. on something, anything in their pipeline.

New buyers aren't going to come from the March/April news merits, and current holders won't be pouring in new money with the status quo from the company.